Non-Hodgkin Lymphoma Pipeline Landscape 2024: Analysis of Over 220 Potential Pharmaceuticals in Development
April 25, 2024 07:41 ET
|
Research and Markets
Dublin, April 25, 2024 (GLOBE NEWSWIRE) -- The "Non-Hodgkin Lymphoma - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.A new comprehensive report has emerged,...
Global Lymphoma Therapeutics Market Report 2023: Sector is Expected to Reach $24.9 Billion by 2029 at a CAGR of 7.8%
June 06, 2023 11:38 ET
|
Research and Markets
Dublin, June 06, 2023 (GLOBE NEWSWIRE) -- The "Global Lymphoma Therapeutics Market Size, Share & Industry Trends Analysis Report By Treatment Type, By Disease Type, By Route of Administration...
Lymphoma Treatment Global Market Report 2022: Technological Advancements, Including the Development of Innovative Immune Checkpoint Inhibitors, Fuel Growth
October 26, 2022 09:43 ET
|
Research and Markets
Dublin, Oct. 26, 2022 (GLOBE NEWSWIRE) -- The "Lymphoma Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" report has been added to ...
Worldwide Lymphoma Treatment Industry to 2026 - Featuring Abbott Laboratories, Novartis and Spectrum Pharmaceuticals Among Others
December 01, 2021 07:53 ET
|
Research and Markets
Dublin, Dec. 01, 2021 (GLOBE NEWSWIRE) -- The "Lymphoma Treatment Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026" report has been added to...